Responding to the US opioid crisis: leveraging analytics to support decision making

An integrated abundance model for estimating county-level prevalence of opioid misuse in Ohio

(2023) Staci A Hepler et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic

(2023) Ruth Hailu et al.   JAMA Network Open

A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea

(2023) Siin Kim et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

Geographic and temporal trends in fentanyl-detected deaths in Connecticut, 2009–2019

(2023) Haidong Lu et al.   ANNALS OF EPIDEMIOLOGY

Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder

(2023) Benjamin Enns et al.   DRUG AND ALCOHOL DEPENDENCE

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts

(2023) Avik Chatterjee et al.   JAMA Network Open

Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States

(2023) Moosa Tatar et al.   AMERICAN JOURNAL ON ADDICTIONS

Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes

(2023) Vanessa A. Palzes et al.   JAMA Health Forum

Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses

(2023) Rebecca Arden Harris et al.   JAMA Health Forum

Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids

(2023) Anneke L. Claypool et al.   JAMA Health Forum

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission

(2022) Keith Humphreys et al.   LANCET

What lessons from Estonia's experience could be applied in the United States in response to the addiction and overdose crisis?

(2022) Katri Abel‐Ollo   ADDICTION

Surveillance for endemic infectious disease outbreaks: Adaptive sampling using profile likelihood estimation

(2022) Michael Fairley et al.   STATISTICS IN MEDICINE

Modeling the evolution of the US opioid crisis for national policy development

(2022) Tse Yang Lim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aiding the prescriber: developing a machine learning approach to personalized risk modeling for chronic opioid therapy amongst US Army soldiers

(2022) Margrét Vilborg Bjarnadóttir et al.   Health Care Management Science

Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

(2022) Christopher M. Jones et al.   JAMA Psychiatry

Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder

(2022) Gary Qian et al.   DRUG AND ALCOHOL DEPENDENCE

Development and Validation of a Machine Learning Model to Estimate Risk of Adverse Outcomes Within 30 Days of Opioid Dispensation

(2022) Vishal Sharma et al.   JAMA Network Open

Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island

(2022) Xiao Zang et al.   JAMA Network Open

Heroin Use Cannot Be Measured Adequately with a General Population Survey

(2021) Peter Reuter et al.   ADDICTION

Cost-effectiveness of Treatments for Opioid Use Disorder

(2021) Michael Fairley et al.   JAMA Psychiatry

Age and generational patterns of overdose death risk from opioids and other drugs

(2020) Hawre Jalal et al.   NATURE MEDICINE

A dynamic model of the opioid drug epidemic with implications for policy

(2020) Jack Homer et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis

(2020) Cora L. Bernard et al.   PLOS MEDICINE

Development of a Cascade of Care for responding to the opioid epidemic

(2019) Arthur Robin Williams et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Modeling cocaine traffickers and counterdrug interdiction forces as a complex adaptive system

(2019) Nicholas R. Magliocca et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic

(2018) Allison L. Pitt et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

(2018) Hawre Jalal et al.   SCIENCE

Minimal Modeling Approaches to Value of Information Analysis for Health Research

(2011) David O. Meltzer et al.   MEDICAL DECISION MAKING

The cost-effectiveness of Vancouver's supervised injection facility

(2008) A. M. Bayoumi et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Drug use in the social networks of heroin and cocaine users before and after drug cessation

(2008) Amy S. Buchanan et al.   DRUG AND ALCOHOL DEPENDENCE